John Parkinson

Lumen Bioscience's C diff therapy, LMN-201, combines four therapeutic proteins that act synergistically to neutralize both the C difficile bacterium and the toxin that causes its virulence directly in the patient’s gastrointestinal tract.

Although there are certain specialties in medicine that seemed to benefit from this newer former of clinical visits, infectious disease and others did not.

The Peggy Lillis Foundation (PLF) for C diff Education & Advocacy has been busy this year in Washington DC with an FDA event and their Summit and Advocacy Day with lawmakers.

The vaccine candidate, M72/AS01E (M72), could potentially become the first new vaccine to help prevent pulmonary TB, a form of active TB, in more than 100 years.

Although the literature and science may change, hanging onto beliefs about therapeutics is a tradition passed down from instructors to learners. A change in this paradigm may be warranted.

This long-time, understudied virus, can fight bacterial infections and may be poised to become an important treatment option in western medicine.

This rare side effect was witnessed in a small number of people post-vaccine administration.

This variant, which is an ancestor of Omicron, is an emerging variant that is being seen most frequently in Utah, California, and New York State.

A small study explored the connection between Postural Orthostatic Tachycardia Syndrome (POTS) and the COVID-19 condition.

The CDC recently published an examination of caseloads looking at patient characteristics, mortality rates, and comparing similarities to past studies on this subject.

Five organizations have updated the 2014 compendium, "Strategies to Prevent Methicillin-Resistant Staphylococcus aureus Transmission and Infection in Acute Care Hospitals." In doing so, they have elevated antimicrobial stewardship from an “additional practice” to an “essential practice.”

As the summer celebrations get underway, food safety remains vital to everyone.

The investigational therapy from Gilead showed effectiveness and safety at 96 weeks.

The Outpatient Automated Stewardship Information System (OASIS) is a platform that allows clinicians the ability to improve their prescribing practices in hopes of delivering a more judicious approach and moving towards stewardship.

The federal agency has identified a total of 5 cases in Florida and Texas within the last two months.

As this annual day of recognition gets underway, free testing can be found throughout the United States.

The strain, identified as EU11, accounts for 1.7% of cases nationwide in the United States.

The film is part of a GSK campaign, Ask2BSure, that addresses this issue.

The vaccine manufacturer has incorporated spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 for its mRNA-1273.815 COVID-19 vaccine.

The CDC reports that during 2020-2021, the mortality rates for COVID-19—associated fungal Infections were significantly higher than non-COVID-19–associated fungal infections.

Biopharmaceutical company, Vaccitech, has developed its VTP-300 vaccine, and is presenting a poster demonstrating positive early data at the ongoing European Association for the Study of the Liver (EASL) Congress 2023.

A company has developed an intelligence platform for better understanding influenza and other viral trends.

In a large observational study, significant information was obtained about protection against acute infection and disease severity in this age group.

The agency said that in recent days a few more suppliers initiated a voluntary recall of additional select packages sold at national stores.

The federal agency explains this increase in 2022 was substantial compared to previous years, and recommends this population be up-to-date on vaccines for it.

The first patient was dosed for this open-label trial.

The American College of Physicians (ACP) CEO says it is important for physicians to move away from this traditional approach to transition to an empathetic style of discussion with patients so they can better relate and help those in need get back on track with their health post-COVID and schedule routine tests and immunizations.

With an estimated 30% of Americans living with a tattoo, the federal agency has developed guidance designed to give manufacturers information and resources to prevent potential health issues.

Metformin was shown to decrease the condition by 41%; whereas, ivermectin and fluvoxamine treatment did not see a clinical benefit.

A new retrospective study found non-oxygen-dependent COVID-19 patients were more likely to experience this phenomenon if they were immunocompromised, receiving concomitant corticosteroids, or had comorbidities.